Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell…
Biotechnology
US, Boston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Aileron Therapeutics, Inc. (ALRN) to it's peer group.
Peer Group
CTMX ABVC MGTA APTX ARTL VCNX EVLO GOVX BPTH AMTI SLRX NLTX TIL BNTC ASMB SABS FWBI CRIS HSTO CBIO NUVB
Compare Together
Loading...